Report Detail
Global Procalcitonin Antibody Market Growth 2019-2024
- RnM2925110 |
- 11 February, 2019 |
- Global |
- 163 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli.Procalcitonin Antibody refers to the specific protein which can qualitatively and quantitatively detect the PCT level. PCT level is a parameter for the diagnosis and monitoring of bacterial inflammatory diseases
Sepsis is a life-threatening organ dysfunction caused by an excessive host immune response to a serious infection. According to the Centers for Disease Control and Prevention (CDC), 1.6 million Americans suffered from sepsis in 2011, of which about 260,000 did not survive. PCT can play a critical role in addressing this clinical challenge and has become a key component of successful sepsis protocols across the U.S. and Europe. PCT levels increase precipitously in patients with severe bacterial infection. PCT is therefore an extremely important biomarker enabling specific differentiation between a severe bacterial infection and other causes of inflammatory reactions.
The technical barriers of procalcitonin antibody are high and the procalcitonin antibody production concentrated large companies including Thermo Fisher, Roche Diagnostics, bioMerieux, HyTest, etc. The sales revenue of top five manufacturers accounted for 37.9% in 2016. Thermo Fisher is the largest manufacturer in the world, which sales reached 2.48g in China.
The manufacture region is concentrated in South China, East China and Southwest China, of which East China is the largest region with the share 24.28% in 2016. The sales shares of Southwest China and South China were 15.59% and 14.79%.
There are companies adding new capacities and aims at the cost and quality leadership which shall improve profitability. As the same time, companies are focusing on technological innovation, equipment upgrades, and process improvements, to reduce costs and improve quality. The competition in procalcitonin antibody market will become more intense.
According to this study, over the next five years the Procalcitonin Antibody market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Procalcitonin Antibody business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Procalcitonin Antibody market by product type, application, key manufacturers and key regions and countries.
This study considers the Procalcitonin Antibody value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Polyclonal Procalcitonin Antibody
Monoclonal Procalcitonin Antibody
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Medical research institutions
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Thermo Fisher
Roche Diagnostics
bioMerieux
HyTest
Wondfo
Ningbo Medicalsystem Biotechnology
Snibe
Vazyme Biotech
Getein Biotech
Hotgen Biotech
Lumigenex
Shanghai Medicine'nest Pharmaceutical
Kitgen
Beijing KeyGen
Fantibody
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Procalcitonin Antibody consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Procalcitonin Antibody market by identifying its various subsegments.
Focuses on the key global Procalcitonin Antibody manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Procalcitonin Antibody with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Procalcitonin Antibody submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Procalcitonin Antibody Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Procalcitonin Antibody Consumption 2014-2024
- 2.1.2 Procalcitonin Antibody Consumption CAGR by Region
- 2.2 Procalcitonin Antibody Segment by Type
- 2.2.1 Polyclonal Procalcitonin Antibody
- 2.2.2 Monoclonal Procalcitonin Antibody
- 2.3 Procalcitonin Antibody Consumption by Type
- 2.3.1 Global Procalcitonin Antibody Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Procalcitonin Antibody Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Procalcitonin Antibody Sale Price by Type (2014-2019)
- 2.4 Procalcitonin Antibody Segment by Application
- 2.4.1 Hospital
- 2.4.2 Medical research institutions
- 2.4.3 Others
- 2.5 Procalcitonin Antibody Consumption by Application
- 2.5.1 Global Procalcitonin Antibody Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Procalcitonin Antibody Value and Market Share by Application (2014-2019)
- 2.5.3 Global Procalcitonin Antibody Sale Price by Application (2014-2019)
3 Global Procalcitonin Antibody by Players
- 3.1 Global Procalcitonin Antibody Sales Market Share by Players
- 3.1.1 Global Procalcitonin Antibody Sales by Players (2017-2019)
- 3.1.2 Global Procalcitonin Antibody Sales Market Share by Players (2017-2019)
- 3.2 Global Procalcitonin Antibody Revenue Market Share by Players
- 3.2.1 Global Procalcitonin Antibody Revenue by Players (2017-2019)
- 3.2.2 Global Procalcitonin Antibody Revenue Market Share by Players (2017-2019)
- 3.3 Global Procalcitonin Antibody Sale Price by Players
- 3.4 Global Procalcitonin Antibody Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Procalcitonin Antibody Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Procalcitonin Antibody Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Procalcitonin Antibody by Regions
- 4.1 Procalcitonin Antibody by Regions
- 4.1.1 Global Procalcitonin Antibody Consumption by Regions
- 4.1.2 Global Procalcitonin Antibody Value by Regions
- 4.2 Americas Procalcitonin Antibody Consumption Growth
- 4.3 APAC Procalcitonin Antibody Consumption Growth
- 4.4 Europe Procalcitonin Antibody Consumption Growth
- 4.5 Middle East & Africa Procalcitonin Antibody Consumption Growth
5 Americas
- 5.1 Americas Procalcitonin Antibody Consumption by Countries
- 5.1.1 Americas Procalcitonin Antibody Consumption by Countries (2014-2019)
- 5.1.2 Americas Procalcitonin Antibody Value by Countries (2014-2019)
- 5.2 Americas Procalcitonin Antibody Consumption by Type
- 5.3 Americas Procalcitonin Antibody Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Procalcitonin Antibody Consumption by Countries
- 6.1.1 APAC Procalcitonin Antibody Consumption by Countries (2014-2019)
- 6.1.2 APAC Procalcitonin Antibody Value by Countries (2014-2019)
- 6.2 APAC Procalcitonin Antibody Consumption by Type
- 6.3 APAC Procalcitonin Antibody Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Procalcitonin Antibody by Countries
- 7.1.1 Europe Procalcitonin Antibody Consumption by Countries (2014-2019)
- 7.1.2 Europe Procalcitonin Antibody Value by Countries (2014-2019)
- 7.2 Europe Procalcitonin Antibody Consumption by Type
- 7.3 Europe Procalcitonin Antibody Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Procalcitonin Antibody by Countries
- 8.1.1 Middle East & Africa Procalcitonin Antibody Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Procalcitonin Antibody Value by Countries (2014-2019)
- 8.2 Middle East & Africa Procalcitonin Antibody Consumption by Type
- 8.3 Middle East & Africa Procalcitonin Antibody Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Procalcitonin Antibody Distributors
- 10.3 Procalcitonin Antibody Customer
11 Global Procalcitonin Antibody Market Forecast
- 11.1 Global Procalcitonin Antibody Consumption Forecast (2019-2024)
- 11.2 Global Procalcitonin Antibody Forecast by Regions
- 11.2.1 Global Procalcitonin Antibody Forecast by Regions (2019-2024)
- 11.2.2 Global Procalcitonin Antibody Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Procalcitonin Antibody Forecast by Type
- 11.8 Global Procalcitonin Antibody Forecast by Application
12 Key Players Analysis
- 12.1 Thermo Fisher
- 12.1.1 Company Details
- 12.1.2 Procalcitonin Antibody Product Offered
- 12.1.3 Thermo Fisher Procalcitonin Antibody Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Thermo Fisher News
- 12.2 Roche Diagnostics
- 12.2.1 Company Details
- 12.2.2 Procalcitonin Antibody Product Offered
- 12.2.3 Roche Diagnostics Procalcitonin Antibody Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Roche Diagnostics News
- 12.3 bioMerieux
- 12.3.1 Company Details
- 12.3.2 Procalcitonin Antibody Product Offered
- 12.3.3 bioMerieux Procalcitonin Antibody Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 bioMerieux News
- 12.4 HyTest
- 12.4.1 Company Details
- 12.4.2 Procalcitonin Antibody Product Offered
- 12.4.3 HyTest Procalcitonin Antibody Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 HyTest News
- 12.5 Wondfo
- 12.5.1 Company Details
- 12.5.2 Procalcitonin Antibody Product Offered
- 12.5.3 Wondfo Procalcitonin Antibody Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Wondfo News
- 12.6 Ningbo Medicalsystem Biotechnology
- 12.6.1 Company Details
- 12.6.2 Procalcitonin Antibody Product Offered
- 12.6.3 Ningbo Medicalsystem Biotechnology Procalcitonin Antibody Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Ningbo Medicalsystem Biotechnology News
- 12.7 Snibe
- 12.7.1 Company Details
- 12.7.2 Procalcitonin Antibody Product Offered
- 12.7.3 Snibe Procalcitonin Antibody Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Snibe News
- 12.8 Vazyme Biotech
- 12.8.1 Company Details
- 12.8.2 Procalcitonin Antibody Product Offered
- 12.8.3 Vazyme Biotech Procalcitonin Antibody Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Vazyme Biotech News
- 12.9 Getein Biotech
- 12.9.1 Company Details
- 12.9.2 Procalcitonin Antibody Product Offered
- 12.9.3 Getein Biotech Procalcitonin Antibody Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Getein Biotech News
- 12.10 Hotgen Biotech
- 12.10.1 Company Details
- 12.10.2 Procalcitonin Antibody Product Offered
- 12.10.3 Hotgen Biotech Procalcitonin Antibody Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Hotgen Biotech News
- 12.11 Lumigenex
- 12.12 Shanghai Medicine'nest Pharmaceutical
- 12.13 Kitgen
- 12.14 Beijing KeyGen
- 12.15 Fantibody
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Procalcitonin Antibody . Industry analysis & Market Report on Procalcitonin Antibody is a syndicated market report, published as Global Procalcitonin Antibody Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Procalcitonin Antibody market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
